These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 8949251)
21. Clinical magnetic resonance spectroscopy of the central nervous system. Ratai EM; Gilberto González R Handb Clin Neurol; 2016; 135():93-116. PubMed ID: 27432661 [TBL] [Abstract][Full Text] [Related]
22. MR spectroscopy: its potential role for drug development for the treatment of psychiatric diseases. Mason GF; Krystal JH NMR Biomed; 2006 Oct; 19(6):690-701. PubMed ID: 16986118 [TBL] [Abstract][Full Text] [Related]
23. [N-acetylaspartate is a biomarker of psychiatric and neurological disorders]. Baymeeva NV; Miroshnichenko II Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(8):94-98. PubMed ID: 26356622 [TBL] [Abstract][Full Text] [Related]
24. Magnetic resonance spectroscopy for studies of neurotransmission in vivo. Mason GF Psychopharmacol Bull; 2003; 37(2):26-40. PubMed ID: 14566212 [TBL] [Abstract][Full Text] [Related]
25. Magnetic resonace imaging study in major psychiatric disorders. Lalitanantpong D; Lalitanantpong S J Med Assoc Thai; 2004 Sep; 87 Suppl 2():S300-8. PubMed ID: 16083207 [TBL] [Abstract][Full Text] [Related]
26. Proton magnetic resonance spectroscopy in Alzheimer's disease, a review. Loos C; Achten E; Santens P Acta Neurol Belg; 2010 Dec; 110(4):291-8. PubMed ID: 21305856 [TBL] [Abstract][Full Text] [Related]
27. Perfusion magnetic resonance imaging in psychiatry. Théberge J Top Magn Reson Imaging; 2008 Apr; 19(2):111-30. PubMed ID: 19363433 [TBL] [Abstract][Full Text] [Related]
28. The Utility of Magnetic Resonance Spectroscopy for Understanding Substance Use Disorders: A Systematic Review of the Literature. Hellem T; Shi X; Latendresse G; Renshaw PF J Am Psychiatr Nurses Assoc; 2015; 21(4):244-75. PubMed ID: 26282670 [TBL] [Abstract][Full Text] [Related]
29. Multiparametric Imaging Analysis: Magnetic Resonance Spectroscopy. Rapalino O; Ratai EM Magn Reson Imaging Clin N Am; 2016 Nov; 24(4):671-686. PubMed ID: 27742109 [TBL] [Abstract][Full Text] [Related]
30. Use of non-invasive neuroradiological methods in research of psychoactive drugs. Henigsberg N; Kovacić Z; Kalember P Psychiatr Danub; 2007 Sep; 19(3):234-7. PubMed ID: 17914326 [TBL] [Abstract][Full Text] [Related]
31. Proton magnetic resonance spectroscopy in pediatric neuroradiology. Moore GJ Pediatr Radiol; 1998 Nov; 28(11):805-14. PubMed ID: 9799306 [TBL] [Abstract][Full Text] [Related]
32. Magnetic resonance spectroscopic methods for the assessment of metabolic functions in the diseased brain. Hall H; Cuellar-Baena S; Dahlberg C; In't Zandt R; Denisov V; Kirik D Curr Top Behav Neurosci; 2012; 11():169-98. PubMed ID: 22076698 [TBL] [Abstract][Full Text] [Related]
33. Role of magnetic resonance spectroscopy in evaluation of congenital/developmental brain abnormalities. Shekdar K; Wang DJ Semin Ultrasound CT MR; 2011 Dec; 32(6):510-38. PubMed ID: 22108216 [TBL] [Abstract][Full Text] [Related]
34. Magnetic resonance spectroscopy studies of GABA in neuropsychiatric disorders. Chang L; Cloak CC; Ernst T J Clin Psychiatry; 2003; 64 Suppl 3():7-14. PubMed ID: 12662128 [TBL] [Abstract][Full Text] [Related]
35. Images of the brain: past as prologue. Wagner HN J Nucl Med; 1986 Dec; 27(12):1929-37. PubMed ID: 3023564 [TBL] [Abstract][Full Text] [Related]
36. N-acetyl-aspartate (NAA) as a correlate of pharmacological treatment in psychiatric disorders: a systematic review. Paslakis G; Träber F; Roberz J; Block W; Jessen F Eur Neuropsychopharmacol; 2014 Oct; 24(10):1659-75. PubMed ID: 25130303 [TBL] [Abstract][Full Text] [Related]
37. Proton magnetic resonance spectroscopy as a probe into the pathophysiology of autism spectrum disorders (ASD): a review. Baruth JM; Wall CA; Patterson MC; Port JD Autism Res; 2013 Apr; 6(2):119-33. PubMed ID: 23436782 [TBL] [Abstract][Full Text] [Related]